Understanding liver crises in sickle cell disease
Molecular Mechanism of Sickle Cell Hepatic Crisis
This study is looking into how sickle cell disease can harm the liver and cause serious problems, with the hope of finding new ways to help prevent these issues for patients.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Versiti Wisconsin, INC. NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-11046709 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms behind liver crises that occur in patients with sickle cell disease (SCD). The study aims to identify how sickle cell disease leads to liver injury and cholestasis, which can be life-threatening. By utilizing advanced techniques and a humanized transgenic model, the research seeks to uncover the biological pathways involved in these complications. The findings could pave the way for new preventive therapies to improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with sickle cell disease, particularly those who have experienced liver complications.
Not a fit: Patients without sickle cell disease or those who have not experienced hepatic crises may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better preventive treatments for liver crises in sickle cell disease patients.
How similar studies have performed: While the specific molecular mechanisms of hepatic crises in sickle cell disease are not well-studied, similar research approaches have shown promise in understanding other complications of sickle cell disease.
Where this research is happening
Milwaukee, United States
- Versiti Wisconsin, INC. — Milwaukee, United States (Active)
Researchers
- Principal investigator: Pradhan-Sundd, Tirthadipa — Versiti Wisconsin, INC.
- Study coordinator: Pradhan-Sundd, Tirthadipa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.